Lon Avo News Today

Advanced Oncotherapy plc (LON:AVO – Get Free Report) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1.77 ($0.02) and traded as low as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares trading […]

Advanced Oncotherapy plc (LON:AVO – Get Free Report)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1.93 ($0.02) and traded as low as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares […]

Advanced Oncotherapy plc (LON:AVO – Get Free Report)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1.93 ($0.02) and traded as low as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares […]

Advanced Oncotherapy plc (LON:AVO – Get Free Report) shares passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 3.18 ($0.04) and traded as low as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume […]

Advanced Oncotherapy plc (LON:AVO – Get Free Report) passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 3.81 ($0.05) and traded as low as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of […]

Advanced Oncotherapy plc (LON:AVO – Get Rating) crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 4.21 ($0.05) and traded as high as GBX 8.70 ($0.11). Advanced Oncotherapy shares last traded at GBX 8 ($0.10), with a volume of 2,502,125 shares trading hands. Advanced […]

"This proposed equity fundraise is the largest in the companys history and it will significantly bolster the companys balance sheet as we remain on...

The pair are also planning to enter into an exclusivity agreement to provide proton therapy services in the Gulf Cooperation Council

About the company Advanced Oncotherapy is a specialist developer and provider of a breakthrough proton therapy system, the LIGHT system, which is the result of 25 years of work at CERN and ADAM. The companys  focus is on developing and supplying technologies to maximise the destructive effect of radiation on tumours whilst minimising damage to the patients healthy tissues. How it is doing 03 Jun 2021 Advanced Oncotherapy PLC (LON:AVO) said it signed a letter of intent with Saba Partners for ...

Advanced Oncotherapy signs letter of intent to supply Saba Partners with proton therapy systems